Events during September 2023
CONGRESS 2023 - The role of a Regional Newborn Screening laboratory
27/09/2023
Newborn screening (NBS) is an essential public health strategy aimed at identifying newborn babies that are affected by certain genetic, metabolic and infectious conditions. NBS enables the early detection and management of several congenital disorders, which if left untreated, may lead to mental retardation and/or death. Early diagnosis and instigation of treatment, along with appropriate long-term care help ensure normal growth and development of the affected individual.
The Sheffield Regional NBS Laboratory is one of the largest newborn screening laboratories in the UK testing around 65,000 newborn bloodspot samples per year and has been an integral part of routine newborn care for the region of South Yorkshire, Lincolnshire and East Midlands. Newborn screening in the United Kingdom now includes screening for 10 conditions including multiple metabolic, haemoglobinopathies and only recently severe combined immunodeficiency - all detectable though multiplex laboratory procedures.
This presentation will briefly review the implementation of newborn screening in the region, including a brief history and justification for newborn screening, laboratory detection and diagnosis of the screening condition, the referral pathway/notification to a regional consultant paediatrician for initiation of treatment of the condition/follow up testing and conclude with a case study.
The Sheffield Regional NBS Laboratory is one of the largest newborn screening laboratories in the UK testing around 65,000 newborn bloodspot samples per year and has been an integral part of routine newborn care for the region of South Yorkshire, Lincolnshire and East Midlands. Newborn screening in the United Kingdom now includes screening for 10 conditions including multiple metabolic, haemoglobinopathies and only recently severe combined immunodeficiency - all detectable though multiplex laboratory procedures.
This presentation will briefly review the implementation of newborn screening in the region, including a brief history and justification for newborn screening, laboratory detection and diagnosis of the screening condition, the referral pathway/notification to a regional consultant paediatrician for initiation of treatment of the condition/follow up testing and conclude with a case study.
CONGRESS 2023 - Your career in Clinical Biochemistry: IBMS qualifications and the role of the Advisory Panel (Wednesday)
27/09/2023
Your career in Clinical Biochemistry: IBMS qualifications and the role of the Advisory Panel
CONGRESS 2023 - The metabolic role of Vitamin B12
27/09/2023
Delegates will understand:
The pathophysiological aspects of Vitamin B12.
The role of the laboratory in the diagnosis of Vitamin B12 deficiency.
The pathophysiological aspects of Vitamin B12.
The role of the laboratory in the diagnosis of Vitamin B12 deficiency.
CONGRESS 2023 - 2pm The metabolic role of Vitamin B12 Clinical Chemistry 2.30pm Lipid disorders Clinical Chemistry Lipid disorders
27/09/2023
This presentation will provide an update Update to the clinical use of lipids and the laboratory role in lipid disorders.
CONGRESS 2023 - Molar pregnancy and gestational trophoblastic disease – why the hCG assay matters
27/09/2023
In this presentation, Imran Jabbar, will delve into the crucial topic of measuring human chorionic gonadotrophin (hCG) in gestational trophoblastic disease (GTD). With a focus on trophoblastic tumours, Imran will explore the significance of hCG as a diagnostic and monitoring tool in GTD. The presentation will cover the principles behind hCG measurement techniques, including immunoassays and molecular methods.
Imran will highlight the challenges and advancements in accurately quantifying hCG levels, and discuss their clinical implications. Attendees will gain insights into the role of hCG measurement in early detection, disease monitoring, and prognostic evaluation, ultimately contributing to improved patient outcomes in GTD management.
Imran will highlight the challenges and advancements in accurately quantifying hCG levels, and discuss their clinical implications. Attendees will gain insights into the role of hCG measurement in early detection, disease monitoring, and prognostic evaluation, ultimately contributing to improved patient outcomes in GTD management.
CONGRESS 2023 - Reporting direct to the patient
27/09/2023
In recent years, healthcare policy has been moving towards the concept of patients being able to receive their pathology test results directly, it is likely that pathology providers may need to consider the communication of some laboratory test results directly to patients.
This is a very different group of people to what pathology providers are used to. Expansion of concepts such as reference intervals and what is significant need to be explored in the context of a more general audience.
This is a very different group of people to what pathology providers are used to. Expansion of concepts such as reference intervals and what is significant need to be explored in the context of a more general audience.
CONGRESS 2023 - Cutting a clinical career as a scientist in histopathology
27/09/2023
The session will provide an overview of the qualifications that the IBMS offers in those who are carving out a career in Histopathology after they have achieved their specialist level qualification. It will outline the DEP and ASD in Histological Dissection, DEP in Immunocytochemistry and the ASD in Histopathology Reporting qualifications and other related qualifications.
It will explain who these qualifications are aimed and provide an outline of how they are assessed, how candidates can achieve these qualifications and what roles successful candidates can go on to undertake.
It will explain who these qualifications are aimed and provide an outline of how they are assessed, how candidates can achieve these qualifications and what roles successful candidates can go on to undertake.
CONGRESS 2023 - Transforming your pathology workforce
27/09/2023
Join your network workforce leads/practice educators for a solution focused discussion around workforce challenges. Find out about current education and development opportunities with specific emphasis on support workers, advanced clinical practice and leadership. We welcome your participation in helping to shape the future of your pathology workforce.
You are invited by the speakers to complete this online form before the presentation
You are invited by the speakers to complete this online form before the presentation
CONGRESS 2023 - Networks – how Greater Manchester is making it work for them
27/09/2023
Networks – how Greater Manchester is making it work for them
CONGRESS 2023 - Shared training – the Scottish Training Academy to Registration Portfolio training
27/09/2023
Shared training – the Scottish Training Academy to Registration Portfolio training
Page 17 of 28